Family Medicine

Review | Prevention of venous thromboembolism in patients with cancer

5 Jun, 2023 | 13:48h | UTC

Prevention of venous thromboembolism in patients with cancer – The BMJ

 

---

Cohort Study | Overweight or obesity in early and middle adulthood linked to higher gastrointestinal cancer risk

5 Jun, 2023 | 13:34h | UTC

Analysis of Body Mass Index in Early and Middle Adulthood and Estimated Risk of Gastrointestinal Cancer – JAMA Network Open

Editorial: Obesity and Gastrointestinal Cancer: A Life Course Perspective – JAMA Network Open

Commentary: Association Between Overweight/Obesity and Risk of Gastrointestinal Cancer – The ASCO Post

 

---

Cohort Study | Cannabis use disorder linked to increased risk of depression and bipolar disorder

5 Jun, 2023 | 13:26h | UTC

Cannabis Use Disorder and Subsequent Risk of Psychotic and Nonpsychotic Unipolar Depression and Bipolar Disorder – JAMA Psychiatry (link to abstract – $ for full-text)

Author Interview: Cannabis Use Disorder and Subsequent Risk of Unipolar Depression and Bipolar Disorder

Commentary: Expert reaction to study of cannabis use disorder, bipolar disorder, and depression – Science Media Centre

 

---

M-A | Efficacy and safety of duloxetine in chronic musculoskeletal pain

5 Jun, 2023 | 13:09h | UTC

Efficacy and safety of duloxetine in chronic musculoskeletal pain: a systematic review and meta-analysis – BMC Musculoskeletal Disorders

 

---

Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050

2 Jun, 2023 | 12:34h | UTC

Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021 – The Lancet Rheumatology

Editorial: The global epidemic of low back pain – The Lancet Rheumatology

News Releases:

New study shows low back pain is the leading cause of disability around the world – Institute for Health Metrics and Evaluation

In 2050, over 800 million people globally estimated to be living with back pain – The University of Sidney

 

Commentary on Twitter

NEW—GBD 2021 data published in @TheLancetRheum finds low back pain is the leading cause of disability globally. #LowBackPain affects 619 million individuals (1 out of every 13 people). More women across all age groups suffered from low back pain than men.https://t.co/A2RoU9hn9p pic.twitter.com/vhXwcVh1e7

— Institute for Health Metrics and Evaluation (IHME) (@IHME_UW) May 22, 2023

 

---

ACR Guideline for exercise, rehabilitation, diet, and additional integrative interventions for rheumatoid arthritis

2 Jun, 2023 | 12:33h | UTC

2022 American College of Rheumatology Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis – Arthritis Care & Research

Editorial: Patient Perspectives on the 2022 American College of Rheumatology Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis – Arthritis Care & Research

News Release: New Guideline Introduces Recommendations for Integrative Approach to RA Treatment – American College of Rheumatology

 

---

Systematic Review | Bupropion and nortriptyline: an assessment of their effectiveness in smoking cessation

2 Jun, 2023 | 12:28h | UTC

Antidepressants for smoking cessation – Cochrane Library

 

---

Systematic review | Analgesic use in sports

2 Jun, 2023 | 12:17h | UTC

Analgesic Use in Sports: Results of a Systematic Literature Review – Deutsches Ärzteblatt International

 

---

Review | Subclinical hypothyroidism: let the evidence be your guide

2 Jun, 2023 | 12:08h | UTC

Subclinical hypothyroidism: Let the evidence be your guide – Journal of Family Practice

 

---

Review | Medication-assisted recovery for opioid use disorder

2 Jun, 2023 | 12:03h | UTC

Medication-assisted recovery for opioid use disorder: A guide – Journal of Family Practice

 

---

Review | These USPSTF recommendations should be on your radar

2 Jun, 2023 | 11:59h | UTC

These USPSTF recommendations should be on your radar – Journal of Family Practice

 

---

ASH 2023 Guidelines for management of venous thromboembolism | Thrombophilia testing

1 Jun, 2023 | 12:22h | UTC

American Society of Hematology 2023 Guidelines for Management of Venous Thromboembolism: Thrombophilia Testing – Blood Advances

 

---

RCT | Dupilumab improves lung function and reduces exacerbations in COPD patients with elevated eosinophils

1 Jun, 2023 | 12:20h | UTC

Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Dupilumab Improves Outcomes for COPD, Type 2 Inflammation in Randomized Trial – HCP Live

 

Commentary on Twitter

Presented at #ATS2023: In the BOREAS trial, dupilumab resulted in a lower annualized rate of exacerbations than placebo among patients with COPD and an elevated blood eosinophil count. Full trial results: https://t.co/9IWZr3YqsN

— NEJM (@NEJM) May 21, 2023

 

---

SR | Systematic review finds 16.4-36.18 severe bleedings, 7.62-8.5 perforations per 10,000 colonoscopies

1 Jun, 2023 | 12:15h | UTC

An Estimate of Severe Harms Due to Screening Colonoscopy: A Systematic Review – The Journal of the American Board of Family Medicine

 

---

Expert Consensus | Nephrotoxic potential of 195 medications in the non-intensive care setting

1 Jun, 2023 | 12:14h | UTC

Expert Consensus on the Nephrotoxic Potential of 195 Medications in the Non-intensive Care Setting: A Modified Delphi Method – Drug Safety

 

---

M-A | Maternal alcohol consumption and the risk of miscarriage in the first and second trimesters

1 Jun, 2023 | 12:10h | UTC

Maternal alcohol consumption and the risk of miscarriage in the first and second trimesters: a systematic review and dose–response meta-analysis – Acta Obstetricia et Gynecologica Scandinavica

 

---

Review | Deprescribing interventions for gabapentinoids in adults

1 Jun, 2023 | 12:05h | UTC

Deprescribing interventions for gabapentinoids in adults: a scoping review – British Journal of Clinical Pharmacology

 

---

RCT | Adapted mindfulness training shows efficacy in reducing elevated office blood pressure

1 Jun, 2023 | 12:03h | UTC

Effect of Adapted Mindfulness Training in Participants With Elevated Office Blood Pressure: The MB‐BP Study: A Randomized Clinical Trial – Journal of the American Heart Association

 

---

Cluster RCT | Point-of-care CRP testing cuts antibiotic prescriptions in respiratory illnesses in primary care

1 Jun, 2023 | 11:58h | UTC

Implementation of point-of-care testing of C-reactive protein concentrations to improve antibiotic targeting in respiratory illness in Vietnamese primary care: a pragmatic cluster-randomised controlled trial – The Lancet Infectious Diseases

Commentary: Use of CRP testing reduced antibiotics for respiratory infections, trial finds – CIDRAP

 

---

Study finds potential glaucoma risk in patients using calcium channel blockers

1 Jun, 2023 | 11:51h | UTC

Association of systemic medication use with glaucoma and intraocular pressure: the E3 Consortium – Ophthalmology

Commentary: Calcium Channel Blocker Use Associated with Higher Prevalence of Glaucoma – HCP Live

 

---

M-A | Labor induction at 39 weeks: improved outcomes but increased shoulder dystocia for nulliparous women

31 May, 2023 | 14:10h | UTC

Comparison of Maternal Labor-Related Complications and Neonatal Outcomes Following Elective Induction of Labor at 39 Weeks of Gestation vs Expectant Management: A Systematic Review and Meta-analysis – JAMA Network Open

 

---

Review | How to approach acute thrombosis and thrombocytopenia

31 May, 2023 | 14:03h | UTC

How to approach acute thrombosis and thrombocytopenia – Clinical Medicine Journal

 

---

The WHO AWaRe (Access, Watch, Reserve) antibiotic book

30 May, 2023 | 12:09h | UTC

The WHO AWaRe (Access, Watch, Reserve) antibiotic book – World Health Organization

 

---

M-A | Shorter vs. longer-term antibiotic treatments for community-acquired pneumonia in children

31 May, 2023 | 13:42h | UTC

Shorter Versus Longer-term Antibiotic Treatments for Community-Acquired Pneumonia in Children: A Meta-analysis – Pediatrics (link to abstract – $ for full-text)

Commentary: Meta-analysis supports shorter antibiotic courses for kids’ pneumonia – CIDRAP

Related:

M-A | Examining shorter antibiotic treatment durations for community acquired pneumonia in adults

Appropriate Use of Short-Course Antibiotics in Common Infections: Best Practice Advice From the American College of Physicians – Annals of Internal Medicine

Efficacy of short-course antibiotic treatments for community-acquired pneumonia in adults: A systematic review and meta-analysis – Antimicrobial Agents and Chemotherapy

Short-Course vs Long-Course Antibiotic Therapy for Children With Nonsevere Community-Acquired Pneumonia: A Systematic Review and Meta-analysis – JAMA Pediatrics

Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children: The SCOUT-CAP Randomized Clinical Trial – JAMA Pediatrics

Short-Course Antimicrobial Therapy for Pediatric Community-Acquired Pneumonia: The SAFER Randomized Clinical Trial – JAMA Pediatrics

Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia: The CAP-IT Randomized Clinical Trial – JAMA

 

---

Cohort Study | Amiodarone linked to higher bleeding risk vs. flecainide or sotalol in atrial fibrillation patients on anticoagulants

30 May, 2023 | 12:01h | UTC

Risk for Bleeding-Related Hospitalizations During Use of Amiodarone With Apixaban or Rivaroxaban in Patients With Atrial Fibrillation: A Retrospective Cohort Study – Annals of Internal Medicine (link to abstract – $ for full-text)

News Release: Amiodarone used with anticoagulant therapy linked to more bleeding-related hospitalizations than flecainide or sotalol – American College of Physicians

Commentary: Amiodarone increases bleeding compared with flecainide or sotalol in patients on anticoagulant therapy – ACP Internist

 

Commentary on Twitter

A study of older adults with #AFib who were treated with #anticoagulants found #amiodarone during apixaban/rivaroxaban use was associated with greater risk for bleeding-related #hospitalizations compared to flecainide or sotalol: https://t.co/cFb1rgGqjt pic.twitter.com/gKlgLXBdb2

— Annals of Int Med (@AnnalsofIM) May 25, 2023

 

---